Evaluation of Clinical Implementation of Machine Learning Based Decision Support for ICU Discharge

NCT ID: NCT05497505

Last Updated: 2022-08-11

Basic Information

• Recruitment Status: UNKNOWN
• Total Enrollment: 1500 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2022-03-10
• Study Completion Date: 2023-06-30

Brief Summary

Unexpected intensive care unit (ICU) readmission is associated with longer length of stay and increased mortality. Bedside decision support may prevent readmission and mortality and may allow optimizing ICU capacity. Using a recently developed and prospectively validated machine learning model that predicts ICU readmission and mortality rate after ICU discharge and shows trends in these predictions over time, we will evaluate the implementation of the European conformity (CE)-marked software based on this model (Pacmed Critical, Pacmed, Amsterdam) by investigating whether the software improves diagnostic accuracy compared to routine clinical evaluation by the treatment team and whether availability of the information from this software leads to changes in discharge management (either postponing or advancing discharge) for patients considered eligible for discharge.

Detailed Description

Rationale: Unexpected intensive care unit (ICU) readmission is associated with longer length of stay and increased mortality. Bedside decision support may prevent readmission and mortality and may allow optimizing ICU capacity. Several attempts to develop prediction models to prevent ICU readmission and/or death after discharge from the ICU for general adult critical care patients have been made previously. Although the performance of Machine Learning models versus physicians has been studied for diagnosing in medical imaging, there is scarce literature prospectively comparing physician's predictive performance when it comes to patient outcomes. In addition, currently, no readmission model is widely implemented nor tested to support ICU discharge

Aim: Using a recently developed and prospectively validated machine learning model that predicts ICU readmission and mortality rate after ICU discharge and shows trends in these predictions over time, we will evaluate the implementation of the European conformity (CE)-marked software based on this model (Pacmed Critical, Pacmed, Amsterdam) by investigating whether the software improves diagnostic accuracy compared to routine clinical evaluation by the treatment team and whether availability of the information from this software leads to changes in discharge management (either postponing or advancing discharge) for patients considered eligible for discharge. In addition, since this is a novel approach in supporting discharge decision support, information will be collected from end-users with respect to interpretability and usability. Furthermore, model and software improvement will take place during this pilot phase, e.g. with respect to out-of-distribution detection for recognizing patients that are insufficiently similar to the data the model was developed on. Results from this study will be used to develop a clinical trial to evaluate effect on readmission rate and/or mortality after ICU discharge, if considered feasible, based on the effect the software has on potentially changing intensivist decisions, and the estimated effect on readmission and mortality during the On-period.

Design: Before-and-after pilot implementation study.

For this evaluation, data will be collected both in the periods in which the Pacmed Critical software will not be available to end-users (Off-period, 3-6 months) and during the actual implementation phase where end-users are able to use the software at potential ICU discharge (On-period, 3-6 months). After the implementation phase an additional Off-period (3-6 months) will follow.

After the morning hand-off procedure the treatment team consisting of intensivists, fellows in intensive care medicine, medical residents, ICU nurses, and consulting medical specialists ('treatment team'), will determine which patients appear to be eligible for discharge to the nursing (non-ICU) ward. For those patients, the attending intensivist will digitally document the following:

For both On- and Off-periods:

• 'ready-for-discharge' status, based on the collective evaluation by the treatment team, taking into account the care that can be provided by the receiving ward based on local ICU discharge protocols. Patients that were initially considered 'eligible for ICU discharge' may thus ultimately be considered and documented as 'not ready-for-discharge'.
• destination nursing ward
• prediction for risk of readmission and/or mortality within 7 days (scale 0-100%), assuming the patient would be discharged
• main factors contributing to that decision
• Self-reporting of confidence of estimation (low-medium-high).
• For patients with a 'ready-for-discharge' decision that were not transferred, at the end of day, to the regular ward the reason for that:

• 'Clinical deterioration'
• 'Insufficient bed capacity nursing ward'
• 'Insufficient isolation capacity nursing ward'

Additionally, during On-periods after reviewing the additional information from Pacmed Critical by the treatment team, the previous questions will be asked again to evaluate if re-evaluation with decision support had effect on that decision, i.e. the 'ready-for-discharge' status was changed.

During every period the final decision to discharge patients from the ICU is at the discretion of the lead unit intensivist responsible for the medical care of those patients and could change based on alterations in clinical condition of the patient (e.g. deterioration) and/or reasons that require re-evaluation of patients eligible for discharge, including the need to admit other patients.

Pseudonymized near real-time data will be extracted in a combined production/research database to perform predictions. The predictions accessed by end-users will be filed together with the additional data collected as specified above. In addition the predicted endpoint (ICU readmission and mortality within 7 days after discharge) will be collected for all patients actually discharged from the ICU.

Depending on whether the participating hospital has already passed the technical implementation (i.e. passed device interface and end-user acceptance) after start of the first Off-period Pacmed Critical will be either used prospectively to make the predictions and store the results at the moment of study documentation of the attending intensivist, or retrospectively. The On-period can only commence after the hospital has fully passed technical implementation in accordance with the CE-documentation.

Conditions

Critical Illness

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: PROSPECTIVE

Study Groups

Discharged patients with decision support (On-period)

For patients that have been evaluated as eligible for discharge: the current ICU discharge process will be followed based on routine clinical evaluation by the treatment team in combination with ICU discharge protocols. In addition, Pacmed Critical will be used as an additional source of information. Final discharge decision will be made by lead unit intensivist responsible for medical care.

Pacmed Critical

Intervention Type: DEVICE

For patients in the On-period, Pacmed Critical will be available as decision support after initial eligibility screening for ICU discharge by treatment team

Discharged patients without decision support (Off-period)

For patients that have been evaluated as eligible for discharge: the current ICU discharge process will be followed based on routine clinical evaluation by the treatment team in combination with ICU discharge protocols. Final discharge decision will be made by lead unit intensivist responsible for medical care.

No interventions assigned to this group

Interventions

Pacmed Critical

For patients in the On-period, Pacmed Critical will be available as decision support after initial eligibility screening for ICU discharge by treatment team

Intervention Type: DEVICE

Eligibility Criteria

Inclusion Criteria

• Admission to intensive care or medium care unit
• Age >= 18 years
• ICU admission > 4 hours
• Eligible for discharge at the discretion of the treatment team by not requiring treatment that can only be provided on the ICU (including but not limited to mechanical ventilation, high flow oxygen, vasopressor/inotropes, continuous renal replacement therapy).

Exclusion Criteria

• No-return (to ICU/MCU) policy and/or palliative/end-of-life care
• Coronavirus disease (COVID)-19
• Patients directly transferred to other hospitals after discharge

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Leiden University Medical Center

OTHER

Sponsor Role: collaborator

Patrick J. Thoral

OTHER

Sponsor Role: lead

Responsible Party

Patrick J. Thoral

Principal Investigator

Responsibility Role: SPONSOR_INVESTIGATOR

Principal Investigators

Patrick J Thoral, MD

Role: STUDY_DIRECTOR

Amsterdam UMC, location VUmc

Locations

Amsterdam UMC, location VUmc

Amsterdam, North Holland, Netherlands

Site Status: RECRUITING

Leiden University Medical Center (LUMC)

Leiden, South Holland, Netherlands

Site Status: RECRUITING

Countries

Netherlands

Central Contacts

Patrick J Thoral, MD

Role: CONTACT

p.thoral@amsterdamumc.nl

+31 20 444 3924

Facility Contacts

Patrick J Thoral, MD

Role: primary

p.thoral@amsterdamumc.nl

+31 20 444 3924

Paul WG Elbers, MD, PhD

Role: backup

p.elbers@amsterdamumc.nl

Anne AH de Hond, MSc

Role: primary

a.a.h.de_hond@lumc.nl

+31 71 526 9111

Sesmu (M.S.) Arbous, MD, PhD

Role: backup

m.s.arbous@lumc.nl

References

Thoral PJ, Fornasa M, de Bruin DP, Tonutti M, Hovenkamp H, Driessen RH, Girbes ARJ, Hoogendoorn M, Elbers PWG. Explainable Machine Learning on AmsterdamUMCdb for ICU Discharge Decision Support: Uniting Intensivists and Data Scientists. Crit Care Explor. 2021 Sep 10;3(9):e0529. doi: 10.1097/CCE.0000000000000529. eCollection 2021 Sep.

Reference Type: BACKGROUND

PMID: 34589713 (View on PubMed)

Thoral PJ, Peppink JM, Driessen RH, Sijbrands EJG, Kompanje EJO, Kaplan L, Bailey H, Kesecioglu J, Cecconi M, Churpek M, Clermont G, van der Schaar M, Ercole A, Girbes ARJ, Elbers PWG; Amsterdam University Medical Centers Database (AmsterdamUMCdb) Collaborators and the SCCM/ESICM Joint Data Science Task Force. Sharing ICU Patient Data Responsibly Under the Society of Critical Care Medicine/European Society of Intensive Care Medicine Joint Data Science Collaboration: The Amsterdam University Medical Centers Database (AmsterdamUMCdb) Example. Crit Care Med. 2021 Jun 1;49(6):e563-e577. doi: 10.1097/CCM.0000000000004916.

Reference Type: BACKGROUND

PMID: 33625129 (View on PubMed)

Related Links

https://www.vumc.nl/zorg/expertisecentra-en-specialismen/intensive-en-mediumcare-volwassenen.htm

Sponsor Corporate Website

Other Identifiers

2021.0528

Identifier Type: -

Identifier Source: org_study_id